PRINCETON, N.J. (AP) — PRINCETON, N.J. (AP) — CytoSorbents Corp. (CTSO) on Tuesday reported a loss of $7.3 million in its first quarter.
On a per-share basis, the Princeton, New Jersey-based company said it had a loss of 17 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.
The blood purification therapy company posted revenue of $9.4 million in the period, which beat Street forecasts. Three analysts surveyed by Zacks expected $8.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a CTSO">Zacks stock report on CTSO at https://www.zacks.com/ap/CTSO